A&R PROSPECTUS AND FINAL PROSPECTUS ACCESSIBLE ON SEDAR TORONTO and DALLAS , May 29, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (" Perimeter " or the " Company "), a commercial-stage medical technology company, is pleased to announce the pricing and terms of its previously announced public offering. The offering is of units of the Company (" Units ") or pre-funded units of the Company in lieu... Read More

TORONTO and DALLAS , May 23, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that it has entered into a Development Support Agreement ("DSA") with Salt Lake City -based Intermountain Health, the largest nonprofit health system in the Intermountain West. This agreement creates the framework for the... Read More

Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , May 13, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its first quarter ended March 31, 2025 and provided a corporate update. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars... Read More

TORONTO and DALLAS , May 8, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its first quarter 2025 financial and operating results after market close on Tuesday, May 13, 2025 . Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and... Read More

First-ever successful pivotal trial of a new intraoperative margin assessment technology in breast cancer Pivotal trial met its primary endpoint with statistically significant reduction in patients with residual cancer during surgery (p-value = 0.0050) and demonstrated super-superiority compared to standard-of-care alone ASBrS presentation highlighted both these previously reported positive topline results and new additional... Read More

TORONTO and DALLAS , April 30, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") announced today that HonorHealth, a leading healthcare system serving more than five million people in the greater Phoenix and Scottsdale areas, is the first in Arizona to deploy the Company's S- Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the... Read More

TORONTO and DALLAS , April 28, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that management will present an update on the Company's business at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Monday, May 5, 2025 at 9:30 a.m. Eastern Time at the Metro Toronto Convention Centre. The... Read More

PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ TORONTO and DALLAS , March 27, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (" Perimeter " or the " Company "), a commercial-stage medical technology company, announced today that it has filed a preliminary short form prospectus (the " Preliminary Prospectus ") with the securities regulatory authorities in the Provinces of British Columbia , Alberta... Read More

TORONTO and DALLAS , March 26, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its fourth quarter and full year ended December 31, 2024 and provided a corporate update. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in... Read More

TORONTO and DALLAS , March 24, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its fourth quarter and full year 2024 financial and operating results after market close on Wednesday, March 26, 2025 . Following the announcement, Perimeter management will host a webcast and conference call to... Read More

TORONTO and DALLAS , March 17, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced the submission of a Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for the Company's next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence... Read More

TORONTO and DALLAS , March 6, 2025 /CNW/ - In advance of International Women's Day, Perimeter Medical Imaging AI , Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), announced today that Covenant Health Fort Sanders Regional is the first hospital in Tennessee to use the Company's S-Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the operating room. "OCT technology enhances... Read More

Pivotal trial met its primary endpoint with statistically significant reduction in patients with residual cancer during surgery (p-value = 0.0050) Presentation will highlight both previously reported positive topline results and new additional analyses, including secondary endpoints and additional reporting TORONTO and DALLAS , March 5, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter"... Read More

TORONTO and DALLAS , Feb. 25, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that its common shares will begin trading on the OTCQX® Best Market under the symbol "PYNKF", effective with the open of business on February 27, 2025 . "Many of our shareholders are based in the United States and the U.S.... Read More

TORONTO and DALLAS , Jan. 30, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that Bristol Investor Relations will host an investor webcast Thursday, February 6, 2025 at 2:00 PM ET . During the webcast, Adrian Mendes , CEO, Andrew Berkeley , CIO, and Sara Brien , CFO, will conduct a presentation that will... Read More

TORONTO and DALLAS , Dec. 3, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, wishes to notify shareholders that in case of disruption due to the ongoing Canada Post strike, the Company's meeting materials (the "Meeting Materials") for the Company's upcoming annual general meeting to be held on December 12, 2024 at 1:00... Read More

Intraoperative margin assessment during BCS using Perimeter B-Series OCT with ImgAssist AI 2.0 enabled surgeons to more effectively address residual cancer at the surgical margin as compared to current standard methods Primary endpoint met with statistically significant reduction in patients with residual cancer during surgery (p-value = 0.0050) B-series super-superiority based on predefined clinical and statistical... Read More

TORONTO and DALLAS , Nov. 18, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced that it will report topline results from the pivotal study evaluating the use of its next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence ("AI") technology with optical coherence tomography... Read More

Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Nov. 14, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its third quarter ended September 30, 2024 and provided a corporate update. Business Highlights The Company continues to gain positive commercial market traction with... Read More

TORONTO and DALLAS , Nov. 8, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK)(OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its third quarter 2024 financial and operating results after market close on Thursday, November 14, 2024 . Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and... Read More

TORONTO and DALLAS , Oct. 10, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the second and final closing (the "Second Closing") of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering"). Under the Second... Read More

Perimeter OCT B-Series is the first system designed to combine AI with optical coherence tomography for margin assessment, with the aim of reducing the unacceptably high reoperation rates associated with BCS Recent study 1 published in the Annals of Surgical Oncology revealed reoperation rates of 21.1% among commercially insured women and 14.9% among the Medicare cohort Primary endpoint results from OCT B-Series pivotal... Read More

TORONTO and DALLAS , Sept. 30, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the closing of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering"). The Company issued 23,470,560 Common Shares at a price... Read More

TORONTO and DALLAS , Sept. 10, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that it is undertaking a non-brokered private placement of up to 32,175,032 common shares in the capital of the Company ("Common Shares") at a price of $0.42 per Common Share, for aggregate gross proceeds of up to approximately... Read More

Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Aug. 14, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its second quarter ended June 30, 2024 and provided a corporate update. Business Highlights The Company continues to gain positive commercial market... Read More

TORONTO and DALLAS , Aug. 7, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its second quarter 2024 financial and operating results after market close on Wednesday, August 14, 2024 . Following the announcement, Perimeter management will host a webcast and conference call to discuss the... Read More

TORONTO and DALLAS , June 19, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company, today announced that it will host a webcast investor presentation on Tuesday, June 25, 2024 at 2:00 PM ET . During the webcast, Adrian Mendes , CEO, Andrew Berkeley , CIO and Sara Brien , CFO, will conduct a presentation that will... Read More

Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , May 14, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its first quarter ended March 31, 2024 and provided a corporate update. Adrian Mendes , Perimeter's Chief Executive Officer stated, "This past quarter we... Read More

TORONTO and DALLAS , May 9, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024 . Following the announcement, Perimeter management will host a webcast and conference... Read More

TORONTO and DALLAS , April 16, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced a newly published webinar, "Trends in Artificial Intelligence (AI) and Innovators in Healthcare" featuring a fireside chat with Anantha Kancherla , former head of Meta's AI platform, and current member of Perimeter's... Read More

TORONTO and DALLAS , April 4, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it will participate in the upcoming American Society of Breast Surgeons (ASBrS), featuring interactive demos of the S-Series OCT device at the Company's booth. The Company also announced the grant of certain stock... Read More

Conference Call/Webcast Today at 4:30 pm ET TORONTO and DALLAS , March 28, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update. Adrian Mendes , Perimeter's Chief Executive Officer stated, "Reflecting... Read More

DALLAS and TORONTO , March 20, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced upcoming events and provided a corporate update on grant funding opportunities to support its next-generation AI technology development. Adrian Mendes , Perimeter's Chief Executive Officer, stated, "As we continue to ramp... Read More

DALLAS and TORONTO , Feb. 29, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced results from a peer-reviewed retrospective study 1 examining the integration of Wide Field Optical Coherence Tomography (WF-OCT) with Perimeter's proprietary and investigational "ImgAssist" artificial intelligence... Read More

DALLAS and TORONTO , Feb. 20, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced results from a new study 1 published in the Annals of Surgical Oncology that provide a comprehensive and up-to-date understanding of population-level reoperation rates and incremental healthcare costs associated with... Read More

DALLAS and TORONTO , Feb. 7, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced further commercial expansion within a major national healthcare system, with a follow-on placement of its flagship Perimeter S-Series OCT system at a new hospital site in North Texas . Adrian Mendes , Perimeter's... Read More

DALLAS and TORONTO , Dec. 14, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced a follow-on commercial placement of its flagship Perimeter S-Series OCT system at a new hospital site within one of the largest healthcare networks in North Texas , which is part of a major national healthcare... Read More

DALLAS and TORONTO , Nov. 27, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced that it will participate in an investor webinar hosted by PropThink Conferences featuring Dr. Amelia Tower , breast surgical oncologist, to discuss the re-excision epidemic and potential benefits of AI in cancer... Read More

Company Announces Appointment of Adrian Mendes to Board of Directors Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Nov. 14, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its third quarter ended September 30, 2023 and provided a corporate update. Quarterly... Read More

Hosting Call on Tuesday, November 14 th at 5 pm ET TORONTO and DALLAS , Nov. 8, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc . (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced it will report its third quarter 2023 financial and operating results after the close of U.S. financial markets on Tuesday, November 14, 2023 . Conference Call/Webcast... Read More

DALLAS and TORONTO , Oct. 31, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the initiation of an additional clinical trial site at the University of Washington / Fred Hutch Cancer Center located in Seattle, WA. Perimeter is conducting an ongoing multi-center, randomized two-arm pivotal clinical... Read More

DALLAS and TORONTO , Oct. 17, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced that it will host an investor webcast presentation on Wednesday, October 25, 2023 , at 2:00 PM ET to provide an overview of key areas of Perimeter's business. Following prepared remarks, investors will have an... Read More

TORONTO and DALLAS , Sept. 13, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that, on September 13, 2023 , it granted 3,523,408 stock options to certain directors, officers, consultants, and employees of the Company. Each stock option entitles the holder to acquire one common share of the Company... Read More

(TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported leadership changes, including the appointment of Suzanne Foster as Chair of its Board of Directors, effective immediately. Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Suzanne is a global industry leader with more than 25 years of healthcare... Read More

Completed two follow-on commercial placements of Perimeter S-Series OCT at the end of 2022 Doubled the commercial installed base of S-Series OCT during Q4 2022 Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC)(“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported two new commercial installations of its flagship Perimeter S-Series OCT system, which were completed... Read More

Research concludes WF-OCT allowed for real-time margin visualization of excised oral and oropharyngeal tissue without impacting specimen integrity or surgical and pathology workflows TORONTO & DALLAS--( BUSINESS WIRE )-- Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck... Read More